SLC1A2 and Huntington disease: Several studies reported a loss of GLT1 (in mice) and EAAT2 (in humans) both at the mRNA and protein level [296,297], increasing with the severity of HD, which opens the possibility of extrasynaptic NMDAR stimulation through spillover of glutamate to perisynaptic sites [298].